Fig. 3From: Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoidsAtypical carcinoid patient referred for restaging with Ga-68 DOTATOC PET/CT and was treated with 3 cycles of peptide receptor radionuclide therapy (PRRT; 2 cycles of Y-90 DOTATOC and 1 cycle of Lu-177 DOTATATE) showing excellent response. a Ga-68 DOTATOC Maximum intensity projection images before PRRT. b Ga-68 DOTATOC maximum intensity projection images 22 months after first PRRTBack to article page